Skip to main content

Table 4 Comparison of the PET/CT results of patients with and without previous ADT

From: Sensitivity and specificity of PET/CT regarding the detection of lymph node metastases in prostate cancer recurrence

 

With hormonal therapy (N = 24)

Without hormonal therapy (N = 25)

True-positive

11/24 (45.8%)

11/25 (44.0%)

False-positive

10/24 (41.7%)

10/25 (40.0%)

True-negative

1/24 (4.2%)

1/25 (4.0%)

False-negative

2/24 (8.3%)

3/25 (12.0%)

Specificity

(9.1%)

(9.1%)

Sensitivity

(84.6%)

(78.6%)